These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28140712)

  • 1. The clinical characteristics and prognostic significance of AID, miR-181b, and miR-155 expression in adult patients with de novo B-cell acute lymphoblastic leukemia.
    Zhou G; Cao Y; Dong W; Lin Y; Wang Q; Wu W; Hua X; Ling Y; Xie X; Hu S; Cen J; Gu W
    Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28140712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.
    Labib HA; Elantouny NG; Ibrahim NF; Alnagar AA
    Hematology; 2017 Aug; 22(7):392-397. PubMed ID: 28253825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
    Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
    Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.
    Shi Y; Zhao X; Durkin L; Rogers HJ; Hsi ED
    Hum Pathol; 2016 Jun; 52():173-8. PubMed ID: 26980048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia.
    Aly RM; Ghazy HF
    Int J Lab Hematol; 2015 Apr; 37(2):272-8. PubMed ID: 25090928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G
    Leukemia; 2010 Jan; 24(1):66-73. PubMed ID: 19759560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
    Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
    J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and Clinical Significance of Exosome Derived MiR-181b-5p in Children with Acute Lymphoblastic Leukemia].
    Hong Y; Liu KK; Wang NL; Xie ZW; Chu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):643-648. PubMed ID: 37356920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
    White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
    J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
    Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
    Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
    Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
    Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and Function of miR-181b in Diffuse Large B Cell Lymphoma].
    He B; Zhu DX; Chao HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1111-1115. PubMed ID: 30111416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic Leukemia].
    Kou Z; Liu H; Wang YC; Huang Q; Wang ZS; Gu ZNE; Lang T; Nie YL; An L; A ZL; Mu HBE; Zhang XY; Fu L; Ai HJ; Mao M; Wang XM; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):808-814. PubMed ID: 32552940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
    Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
    Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.
    Rodríguez-Hernández G; Opitz FV; Delgado P; Walter C; Álvarez-Prado ÁF; González-Herrero I; Auer F; Fischer U; Janssen S; Bartenhagen C; Raboso-Gallego J; Casado-García A; Orfao A; Blanco O; Alonso-López D; Rivas JL; Tena-Dávila SG; Müschen M; Dugas M; Criado FJG; Cenador MBG; Vicente-Dueñas C; Hauer J; Ramiro AR; Sanchez-Garcia I; Borkhardt A
    Nat Commun; 2019 Dec; 10(1):5563. PubMed ID: 31804490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
    de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
    Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.